News: ANP Antisense Therapeutics says ATL1102 for MS Phase IIb IND submitted to FDA for review, page-11

You and all other shareholders just got raped.
History repeats itself.... Diamond stays in power with a new friend who has walked away with 20% of the company .
Poor old Leon who blew 750k at the last cr at 11c must have egg on face to see his investment blown apart.
My opinion is that it's an absolute insult to all shareholders to be diluted so cheaply after suggesting licensing deals, Eap revenues, non dilutive funding and promising change at the last 2 agms.
What a load of rubbish and there is no way on earth I would invest 1 cent in this capital destroying company.